SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-038134
Filing Date
2007-05-10
Accepted
2007-05-10 14:02:04
Documents
6
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a07-10754_110q.htm 10-Q 455484
2 EX-10.58 a07-10754_1ex10d58.htm EX-10.58 236879
3 EX-10.59 a07-10754_1ex10d59.htm EX-10.59 24454
4 EX-31.1 a07-10754_1ex31d1.htm EX-31.1 11170
5 EX-31.2 a07-10754_1ex31d2.htm EX-31.2 11239
6 EX-32 a07-10754_1ex32.htm EX-32 9176
  Complete submission text file 0001104659-07-038134.txt   749913
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 07836667
SIC: 2834 Pharmaceutical Preparations